ATE338056T1 - Steroid sulfataseinhibitoren, verfahren zu ihrer herstellung und ihre verwendung - Google Patents

Steroid sulfataseinhibitoren, verfahren zu ihrer herstellung und ihre verwendung

Info

Publication number
ATE338056T1
ATE338056T1 AT00904516T AT00904516T ATE338056T1 AT E338056 T1 ATE338056 T1 AT E338056T1 AT 00904516 T AT00904516 T AT 00904516T AT 00904516 T AT00904516 T AT 00904516T AT E338056 T1 ATE338056 T1 AT E338056T1
Authority
AT
Austria
Prior art keywords
production
steroid sulfatase
sulfatase inhibitors
disclosed
compounds
Prior art date
Application number
AT00904516T
Other languages
English (en)
Inventor
Pui-Kai Li
Shiro Akinaga
Chikara Murakata
Original Assignee
Univ Holy Ghost Duquesne
Kyowa Hakko Kogyo Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Holy Ghost Duquesne, Kyowa Hakko Kogyo Kk filed Critical Univ Holy Ghost Duquesne
Application granted granted Critical
Publication of ATE338056T1 publication Critical patent/ATE338056T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0072—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the A ring of the steroid being aromatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C07J41/0011—Unsubstituted amino radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0066—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by a carbon atom forming part of an amide group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0073—Sulfur-containing hetero ring
    • C07J71/0094—Sulfur-containing hetero ring containing sulfur and nitrogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
AT00904516T 1999-01-25 2000-01-24 Steroid sulfataseinhibitoren, verfahren zu ihrer herstellung und ihre verwendung ATE338056T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/236,842 US6288050B1 (en) 1997-07-18 1999-01-25 Steroid sulfatase inhibitors and methods for making and using the same

Publications (1)

Publication Number Publication Date
ATE338056T1 true ATE338056T1 (de) 2006-09-15

Family

ID=22891204

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00904516T ATE338056T1 (de) 1999-01-25 2000-01-24 Steroid sulfataseinhibitoren, verfahren zu ihrer herstellung und ihre verwendung

Country Status (16)

Country Link
US (2) US6288050B1 (de)
EP (1) EP1147124B1 (de)
JP (1) JP3913475B2 (de)
KR (1) KR20010108127A (de)
CN (1) CN1159337C (de)
AT (1) ATE338056T1 (de)
AU (1) AU768677C (de)
BR (1) BR0008437A (de)
CA (1) CA2361168A1 (de)
DE (1) DE60030410T2 (de)
ES (1) ES2272256T3 (de)
HU (1) HUP0200096A3 (de)
MX (1) MXPA01007506A (de)
NO (1) NO318836B1 (de)
NZ (1) NZ512923A (de)
WO (1) WO2000043408A2 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6476011B1 (en) * 1991-08-28 2002-11-05 Sterix Limited Methods for introducing an estrogenic compound
JP2000309599A (ja) * 1999-04-13 2000-11-07 Kyowa Hakko Kogyo Co Ltd エストラ−１，３，５（１０），１６−テトラエン誘導体
US7335650B2 (en) 2000-01-14 2008-02-26 Sterix Limited Composition
AU2001248849A1 (en) 2000-04-24 2001-11-07 Kyowa Hakko Kogyo Co. Ltd. Estra-1,3,5(10)-triene derivatives
US7125565B2 (en) 2000-12-01 2006-10-24 Kyowa Hakko Kogyo Co., Ltd. Composition improved in the solubility or oral absorbability
US8026229B2 (en) * 2001-08-13 2011-09-27 Sterix Limited Antitumor-active 2-alkoxyestradiol sulfamates
EP1450839A4 (de) * 2001-11-06 2009-06-24 Serono Lab Verfahren zur behandlung von auf östrogen ansprechendem brustkrebs
US20050079156A1 (en) * 2001-11-06 2005-04-14 Grace Wong Method of treating endometreosis
US20040042416A1 (en) * 2002-08-27 2004-03-04 Ngo Chuong Ngoc Virtual Local Area Network auto-discovery methods
WO2004035089A1 (ja) * 2002-10-09 2004-04-29 Kyowa Hakko Kogyo Co., Ltd. ホルモン依存性癌の治療剤
EA011123B1 (ru) * 2003-03-24 2008-12-30 Стерикс Лимитед Производные эстрогена в качестве ингибиторов стероидной сульфатазы
GB0306717D0 (en) * 2003-03-24 2003-04-30 Sterix Ltd Compound
WO2005095437A1 (ja) * 2004-03-30 2005-10-13 Kyowa Hakko Kogyo Co., Ltd. ステロイド誘導体の製造法
EP3071541B1 (de) 2013-11-21 2023-06-07 Marquette University Substituierte (4'-hydroxyphenyl)cycloalkanverbindungen und verwendungen davon als selektive agonisten der östrogenrezeptor-isoform beta
EP3873479A4 (de) * 2018-11-01 2022-08-03 The Regents of the University of California Verbindungen, zusammensetzungen und verfahren zur behandlung von androgenvermittelter erkrankung

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE86393C (de)
GB9118478D0 (en) * 1991-08-29 1991-10-16 Imperial College Steroid sulphatase inhibitors
GB9118465D0 (en) 1991-08-29 1991-10-16 Imperial College Steroid sulphatase inhibitors
US5556847A (en) 1994-10-27 1996-09-17 Duquesne University Of The Holy Ghost Methods of effecting memory enhancement mediated by steroid sulfatase inhibitors
US5571933A (en) 1994-11-17 1996-11-05 Duquesne University Of The Holy Ghost Derivatives of estra 1,3,5(10)triene-17-one, 3-amino compounds and their use
US5567831A (en) 1995-08-16 1996-10-22 Duguesne University Of The Holy Ghost Non-steroidal sulfatase inhibitor compounds and their method of use
DE19540233B4 (de) * 1995-10-19 2005-08-25 Schering Ag Sulfamat-Derivate von 1,3,5(10)-Estratrien-Derivaten, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
US5763492A (en) 1996-10-01 1998-06-09 Duguesne University Of The Holy Ghost Methods for effecting memory enhancement mediated by non-steroidal sulfatase inhibitors
US5763432A (en) 1997-01-29 1998-06-09 Sri International Steriod inhibitors of estrone sulfatase and associated pharmaceutical compositions and methods of use
US5880115A (en) * 1997-07-18 1999-03-09 Duquesne University Of The Holy Ghost Steroid sulfatase inhibitors and methods for making and using the same
US6046186A (en) 1997-12-24 2000-04-04 Sri International Estrone sulfamate inhibitors of estrone sulfatase, and associated pharmaceutical compositions and methods of use

Also Published As

Publication number Publication date
EP1147124B1 (de) 2006-08-30
NZ512923A (en) 2003-01-31
AU2625900A (en) 2000-08-07
AU768677C (en) 2004-11-11
JP3913475B2 (ja) 2007-05-09
NO20013632L (no) 2001-09-03
KR20010108127A (ko) 2001-12-07
BR0008437A (pt) 2001-10-30
EP1147124A2 (de) 2001-10-24
CN1159337C (zh) 2004-07-28
DE60030410D1 (de) 2006-10-12
JP2002535340A (ja) 2002-10-22
DE60030410T2 (de) 2007-08-30
US6288050B1 (en) 2001-09-11
NO318836B1 (no) 2005-05-09
NO20013632D0 (no) 2001-07-24
HUP0200096A3 (en) 2003-01-28
CA2361168A1 (en) 2000-07-27
CN1340056A (zh) 2002-03-13
WO2000043408A3 (en) 2000-11-30
ES2272256T3 (es) 2007-05-01
US6399595B1 (en) 2002-06-04
AU768677B2 (en) 2003-12-18
MXPA01007506A (es) 2003-06-24
WO2000043408A2 (en) 2000-07-27
HUP0200096A2 (hu) 2002-07-29

Similar Documents

Publication Publication Date Title
ATE250077T1 (de) Steroid sulfataseinhibitoren, verfahren zu ihrer herstellung und verwendung
ATE338056T1 (de) Steroid sulfataseinhibitoren, verfahren zu ihrer herstellung und ihre verwendung
DE60033028D1 (de) 5-pyridyl-1,3-azol-derivate, verfahren zu ihrer herstellung und ihre verwendung
DK1090029T3 (da) 14,15-Cyclopropansteroider fra 19-norandrostan-rækken, fremgangsmåde til deres fremstilling, og farmaceutiske præparater indeholdende disse forbindelser
AU5276600A (en) Kit for flushing medical devices and method of preparing the flushing solution
ATE271037T1 (de) Substituierte karbazole, verfahren zu ihrer herstellung und ihre verwendung als spla2- inhibitoren
EA200001129A2 (ru) Способ получения 4-карбоксиамино-2-замещенного-1,2,3,4-тетрагидрохинолина
ATE327981T1 (de) Arylisoxazolin-derivative, verfahren zu ihrer herstellung und ihre verwendung als schädlingsbekämpfungsmittel
EP0367576A3 (de) Östrogenkernderivate und deren Gebrauch als Inhibitoren von sexuellen Steroiden
DE69838146D1 (de) Androgene steroidderivate und ein verfahren zur herstellung und verwendung derselben
ATE267202T1 (de) 1,4-diazabicyclo(3.2.2)nonanbenzoxazol-, benzothiazol- und benzoimidazolderivate, verfahren zu ihrer herstellung und ihre therapeutische verwendung
WO2001001974A3 (en) Naaladase inhibitors in anxiety and memory disorders
AU2002220036A1 (en) Method and system for improving stability of photomasks
DE50012584D1 (de) Keramikhaltiges dispergat, verfahren zu dessen herstellung und verwendung des dispergates in dickschichtpasten
NO20053626L (no) Blanding omfattende en kombinasjon av en aromataseinhibitor, et progestin og et ostrogen for anvendelse av behandling av endomeriose
DE60205717D1 (de) 2-arylimino-2,3-dihydrothiazol derivate, verfahren zu ihrer herstellung und ihre therapeutische verwendung
DE60120990D1 (de) Verwendung von 3-bezoylphenylessigsäure-derivaten zur behandlung von netzhauterkrankungen
HUP0202371A3 (en) Diacylhydrazine derivatives, process for producing them, use of these derivatives for producing of pharmaceutical compositions and pharmaceutical compositions
EP1483233A4 (de) Substituierte tetrahydro isochinolinverbindungen, verfahren zu deren herstellung und deren verwendung
IS6063A (is) Nýjar morfólínafleiður, aðferð til framleiðslu þeirra og lyfjablöndur sem innihalda þessar afleiður
ATE238779T1 (de) Steroidhaltiges pflaster, verfahren zu seiner herstellung und verwendung
ATE218558T1 (de) 4-(1-piperazinyl)benzosäurederivate, verfahren zu ihrer herstellung und ihre therapeutischen verwendungen
ATE269853T1 (de) Benzoxa- und benzthiazolylsulfamate sowie ihre verwendung als steroid-sulfataseinhibitoren
NO20022896D0 (no) Substituerte 1- og 2-naftol mannich baser
ATE267206T1 (de) 5-imino-13-deoxy-antracyclin-derivate, ihre verwendung sowie verfahren zu deren herstellung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties